Ironwood Pharmaceuticals, Inc. (IRWD) financial statements (2020 and earlier)

Company profile

Business Address 100 SUMMER STREET, SUITE 2300
BOSTON, MA 02110
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments177173221305439248198
Cash and cash equivalents177173126542617475
Short-term investments  96251178174122
Restricted cash and investments11     
Receivables11781826555263
Inventory, net of allowances, customer advances and progress billings1 11 522
Inventory1 11 522
Other undisclosed current assets1111796116
Total current assets:307266312380500290229
Noncurrent Assets
Operating lease, right-of-use asset18
Property, plant and equipment12171721213037
Long-term investments and receivables33      
Accounts and financing receivable, after allowance for credit loss33      
Intangible assets, net (including goodwill)11161167  
Goodwill1111   
Intangible assets, net (excluding goodwill)  160166   
Derivative instruments and hedges314110813386  
Restricted cash and investments16 8988
Other noncurrent assets0011364
Other undisclosed noncurrent assets  7    
Total noncurrent assets:96662943301194450
TOTAL ASSETS:403332606710619334279
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities34605456325042
Accounts payable418161891010
Accrued liabilities11151338232318
Employee-related liabilities192624  1714
Interest and dividends payable011  1 
Deferred revenue1
Debt1484628121
Deferred rent credit 0
Restructuring reserve03    
Due to related parties2  000 
Business combination, contingent consideration, liability 0014  
Deferred revenue and credits0813128
Other undisclosed current liabilities38774(14)(10)
Total current liabilities:411206691766141
Noncurrent Liabilities
Long-term debt and lease obligation430366 132133165178
Long-term debt, excluding current maturities408366 132133162175
Capital lease obligations0 0033
Operating lease, liability22
Liabilities, other than long-term debt2543134185942022
Deferred revenue and credits5182020
Deferred rent credit 6
Other liabilities135810 2
Business combination, contingent consideration, liability  3163  
Derivative instruments and hedges, liabilities24349211375  
Total noncurrent liabilities:455409134318227184200
Total liabilities:496528200409303245241
Stockholders' equity
Stockholders' equity attributable to parent, including:(93)(196)1067958938
Common stock0      
Additional paid in capital1,4791,3951,3191,2581,2051,056816
Accumulated other comprehensive income (loss)  (0)(0)(0)(0)0
Accumulated deficit(1,572)(1,591)(1,309)(1,192)(1,110)(967)(778)
Other undisclosed stockholders' equity attributable to parent 000000
Total stockholders' equity:(93)(196)1067958938
Other undisclosed liabilities and equity  396234221  
TOTAL LIABILITIES AND EQUITY:403332606710619334279

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues4283472982741507623
Cost of revenue(24)(33)(19)(2)(0)(26)(7)
Cost of goods and services sold(24)(33) (0)(18)(20) 
Gross profit:4053142792721505116
Operating expenses(291)(584)(388)(314)(234)(221)(226)
Other undisclosed operating income (loss)73131(10)(18)1(41)
Operating income (loss):120(239)(77)(52)(102)(169)(252)
Nonoperating expense(61)(43)(40)(30)(41)(20)(21)
Investment income, nonoperating6(6)(1)9(9)00
Interest and debt expense(31)(38)(2)(39)(31)(21)(21)
Other undisclosed income from continuing operations before equity method investments, income taxes      21
Income (loss) from continuing operations before income taxes:28(320)(119)(121)(174)(211)(273)
Other undisclosed income from continuing operations31      
Income (loss) from continuing operations:59(320)(119)(121)(174)(211)(273)
Loss from discontinued operations(37)      
Income (loss) before gain (loss) on sale of properties:22(320)(119)(121)(174)(211)(273)
Other undisclosed net income 382    
Net income (loss) attributable to parent:22(282)(117)(121)(174)(211)(273)
Other undisclosed net income available to common stockholders, basic   393121 
Net income (loss) available to common stockholders, diluted:22(282)(117)(82)(143)(190)(273)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):22(282)(117)(121)(174)(211)(273)
Comprehensive income (loss):22(282)(117)(121)(174)(211)(273)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 0(0)393121(0)
Comprehensive income (loss), net of tax, attributable to parent:22(282)(117)(82)(143)(190)(273)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: